The FTSE 100 index had a weak start, posting its poorest opening in three weeks, as industrial miners and lenders dragged it down.
The FTSE 100 index had a weak start, posting its poorest opening in three weeks, as industrial miners and lenders dragged it down.
This week is filled with busy results announcements for London-listed companies, with big names like Barclays and NatWest, AstraZeneca and GSK, Unilever and Reckitt Benckiser, as well as US tech
The FTSE 100 achieved a new record high with the help of positive corporate earnings from Centrica and Standard Chartered, while higher commodity prices buoyed miners.
The FTSE 100 has ended the trading day on another record high, closing 1.42pc higher at 7,947.60 points.
The FTSE 100 reached an all-time record, buoyed in part by a string of positive earnings and merger talks linked to Standard Chartered.
The record-breaking closing high of the FTSE 100 has been broken by more big names in London’s index. They will be reporting results for the week ahead that could push
As nightfall creeps up ever earlier on us and we begin to wake up in the dark, searching for the comfort of our warmest and cosiest clothing before leaving the
DeepMatter Group Plc (AIM: DMTR, “DeepMatter”, the “Group”), which focuses on digitalising chemistry, announces that its CEO, Mark Warne, has been invited to chair the Industrial Advisory Board (IAB) at
AstraZeneca’s Forxiga (dapagliflozin), has been approved by the European Commission (EC). It is now available for chronic kidney disease (CKD), in adults with or without type-2 diabetes (T2D), in the
DeepMatter collaborates with the University of Cambridge’s Innovation Centre in Digital Molecular Technologies
GSK, the pharmaceutical giant, plans to open a PS400m science hub at Stevenage. This could lead to up to 5,000 new jobs. Work is expected to start in 2022.